Barclay Buck A. Phillips
2017
In 2017, Barclay Buck A. Phillips earned a total compensation of $3.3M as Chief Financial Officer and Senior Vice President, Corporate Development at G1 Therapeutics.
Compensation breakdown
| Option Awards | $3,296,127 |
|---|---|
| Salary | $50,455 |
| Total | $3,346,582 |
Phillips received $3.3M in option awards, accounting for 98% of the total pay in 2017.
Phillips also received $50.5K in salary.
Rankings
In 2017, Barclay Buck A. Phillips' compensation ranked 3,178th out of 14,666 executives tracked by ExecPay. In other words, Phillips earned more than 78.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,178 out of 14,666 | 78th |
Division Manufacturing | 1,091 out of 5,772 | 81st |
Major group Chemicals And Allied Products | 300 out of 2,075 | 86th |
Industry group Drugs | 230 out of 1,731 | 87th |
Industry Pharmaceutical Preparations | 181 out of 1,333 | 86th |
Source: SEC filing on April 18, 2018.
Phillips' colleagues
We found three more compensation records of executives who worked with Barclay Buck A. Phillips at G1 Therapeutics in 2017.